Cargando…
Inhibition of PPARα Induces Cell Cycle Arrest and Apoptosis, and Synergizes with Glycolysis Inhibition in Kidney Cancer Cells
Renal cell carcinoma (RCC) is the sixth most common cancer in the US. While RCC is highly metastatic, there are few therapeutics options available for patients with metastatic RCC, and progression-free survival of patients even with the newest targeted therapeutics is only up to two years. Thus, nov...
Autores principales: | Abu Aboud, Omran, Wettersten, Hiromi I., Weiss, Robert H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737191/ https://www.ncbi.nlm.nih.gov/pubmed/23951092 http://dx.doi.org/10.1371/journal.pone.0071115 |
Ejemplares similares
-
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
por: Trott, Josephine F., et al.
Publicado: (2016) -
α‐Fetoprotein fragment synergizes with sorafenib to inhibit hepatoma cell growth and migration and promote the apoptosis
por: Wang, Qiujiao, et al.
Publicado: (2022) -
Isoliensinine induces cervical cancer cell cycle arrest and apoptosis by inhibiting the AKT/GSK3α pathway
por: Li, Hong-Li, et al.
Publicado: (2022) -
Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway
por: Wang, Gang, et al.
Publicado: (2016) -
Specific Inhibition of the Nuclear Exporter Exportin-1 Attenuates Kidney Cancer Growth
por: Wettersten, Hiromi I., et al.
Publicado: (2014)